Suzhou Zelgen Biopharmaceuticals Co.,Ltd. (SHA:688266)

SHA:688266 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	28,853	16,494	14,014	10,008	14,112	15,526
Market Cap Growth	17.70%	17.70%	40.02%	-29.08%	-9.11%	-
Enterprise Value	27,572	15,213	12,658	9,443	13,028	13,956
Last Close Price	109.00	62.31	52.94	41.70	58.80	64.69
Forward PE	-	35.51	35.51	35.51	-	-
PS Ratio	54.53	30.89	36.26	33.11	74.13	561.28
PB Ratio	22.14	12.66	8.52	12.71	11.26	9.18
P/TBV Ratio	13.20	13.20	8.96	14.98	13.07	10.43
EV/Sales Ratio	51.64	28.49	32.76	31.24	68.44	504.55
Debt / Equity Ratio	0.71	0.71	0.54	0.70	0.18	0.03
Asset Turnover	-	-	0.17	0.18	0.10	0.02
Inventory Turnover	-	-	0.30	0.37	0.19	0.04
Quick Ratio	-	-	2.08	1.57	3.35	11.37
Current Ratio	-	-	2.22	1.77	3.69	11.85
Return on Equity (ROE)	-9.24%	-9.24%	-24.27%	-47.59%	-31.38%	-35.20%
Return on Assets (ROA)	-	-	-10.91%	-19.70%	-17.02%	-20.80%
Return on Capital (ROIC)	-4.03%	-4.03%	-12.84%	-23.92%	-19.64%	-25.32%
Earnings Yield	-0.47%	-0.83%	-1.99%	-4.57%	-3.20%	-2.06%
FCF Yield	-	-2.11%	-4.59%	-3.72%	-2.59%
Buyback Yield / Dilution	-4.50%	-4.50%	-6.74%	0.19%	-2.20%	-30.61%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.